T 0330/24 (PCV2 immunogenic composition/BOEHRINGER INGELHEIM) of 10.02.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T033024.20260210
- Date of decision
- 10 February 2026
- Case number
- T 0330/24
- Online on
- 14 April 2026
- Petition for review of
- -
- Application number
- 16185663.8
- IPC class
- A61K 39/12
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PCV2 immunogenic composition for lessening clinical symptoms in pigs
- Applicant name
- Boehringer Ingelheim Animal Health USA Inc.
- Opponent name
- Laboratorios Hipra, S.A.
Ceva Sante Animale
Elanco US Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 76(1)
- Keywords
- Divisional application - subject-matter extends beyond content of earlier application (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.